📰 Exact Sciences News
Page 45 - Exact Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences. Real-time updates on events, politics, business and more.
June 22, 2023
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target raised by investment analysts at Citigroup from $100.00 to $130.00 in a research report issued on Thursday, The Fly reports. Citigroup’s price target would indicate a potential upside of 44.80% from the company’s previous close. Several other research analysts have also recently issued reports on […]
June 22, 2023
Both companies have outperformed the market over the past year.
June 21, 2023
(Reuters) - Exact Sciences said on Tuesday its next-generation screening test for colon cancer showed 30% lower false positive rate for detecting the ...
June 21, 2023
TAU Medical School Is Dropping the Sackler Name After Years of Pressure Over the Family Firm's Connection to the Opioid Crisis, Joining Oxford University and the Guggenheim and Metropolitan Museums in New York
June 21, 2023
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced separate collaborations with...
June 21, 2023
With U.S. stock markets set to open in two hours, (EXAS) was up 8.1% in pre-market trading, and (PARAA) was up 3.2%. (COIN), (MFC), and (BEPC) were all...
June 21, 2023
Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Wednesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for 
June 21, 2023
Exact Sciences Co. (NASDAQ:EXAS – Get Rating)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $94.34, but opened at $99.00. Exact Sciences shares last traded at $96.19, with a volume of 820,975 shares. Wall Street Analysts Forecast Growth Several research analysts have recently weighed in on […]